Clinical Trial Update: Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating lisdexamfetamine for bipolar depression was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc. | Conditions: Bipolar Depression | Phase 4 | Status: TERMINATED | Results posted: 2013-01-30